|
DiaSino Laboratories
anti-sars-cov-2 elisa kit ![]() Anti Sars Cov 2 Elisa Kit, supplied by DiaSino Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/igg+s1+quant/sars+cov+2+s1+rbd+igg+enzyme+linked+immune+sorbent+assay++elisa++kit/med_rxiv__2021__11__15__21266338-30-24-26 Average 90 stars, based on 1 article reviews
anti-sars-cov-2 elisa kit - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
EUROIMMUN
anti-sars-cov-2 quantivac elisa (igg ![]() Anti Sars Cov 2 Quantivac Elisa (Igg, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/igg+s1+quant/anti+sars+cov+2+elisa++igg+/med_rxiv__2021__02__19__21252080-3-12-7 Average 90 stars, based on 1 article reviews
anti-sars-cov-2 quantivac elisa (igg - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
EUROIMMUN
igg s1 quant igg spike ![]() Igg S1 Quant Igg Spike, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/igg+s1+quant/s1+igg+elisa/pmc08888213__21___1885___Techapp___s1-19-161-160 Average 90 stars, based on 1 article reviews
igg s1 quant igg spike - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Abbott Laboratories
anti s1 igg ![]() Anti S1 Igg, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/igg+s1+quant/2+anti+assay+cov+igg+ii+quant+sars/pm38967518-38-17-25 Average 86 stars, based on 1 article reviews
anti s1 igg - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Enzyme Immunoassay for the Quantitative Estimation of IgG Antibodies to Spike S1+S2 protein in Mouse serum
|
Buy from Supplier |
|
Enzyme Immunoassay for the Quantitative Estimation of Anti-SARS-CoV-2 (2019-nCoV) Spike S1 antibodies in Human serum.
|
Buy from Supplier |
|
Enzyme Immunoassay for the Quantitative Estimation of IgG Antibodies to Human SARS-CoV-2 (Covid-19) spike S1+S2 Delta/Delta Plus Variant (B.1.617.2, AY.1, AY.2) in Human serum
|
Buy from Supplier |
|
Enzyme Immunoassay for the Quantitative Estimation of IgG Antibodies to Spike S1+S2 ECD protein in Human serum
|
Buy from Supplier |
|
Human Anti-SARS-CoV-2 (Covid-19) IgG Antibody to spike protein S1 Quantitative TITRA- TION ELISA
|
Buy from Supplier |
|
Anti-SARS-CoV-2 S1 (RBD) IgG Quantitative ELISA Assay
|
Buy from Supplier |
|
Rabbit Anti-SARS-CoV-2 (Covid-19) IgG Antibody To Spike Protein S1 Mutation D614G Quantitative TITRATION ELISA
|
Buy from Supplier |
Image Search Results
Journal: medRxiv
Article Title: Comparative analysis of antibody production by mRNA 1273, AZD 1222 and BBIBP-CorV on elderly people suffering from different co-morbidity in Bangladesh
doi: 10.1101/2021.11.15.21266338
Figure Lengend Snippet: SARS-CoV-2 Anti S1 RBD IgG comparison among different COVID-19 vaccine recipients after completing both dosage
Article Snippet: Antibodies to the RBD of the S1 subunit of the viral spike protein (IgG) were performed from the plasma samples using a commercially available
Techniques:
Journal: medRxiv
Article Title: In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients
doi: 10.1101/2021.02.19.21252080
Figure Lengend Snippet: Bivariate comparisons shown as scatter plots for quantitative Ro-RBD-Ig-quant vs non-quantitative EI-S1-IgG-quant ( A ) and vs non-quantitative Ro-N-Ig ( B ); for quantitative EI-S1-IgG-quant vs non-quantitative EI-S1-IgG-quant ( C ) and vs non-quantitative Ro-N-Ig ( D ); for quantitative Ro-RBD-Ig-quant vs quantitative EI-S1-IgG-quant ( E ). Dashed lines represent manufacturers’ cut-off values. Red asterisks represent the WHO-standards (from the left to the right: 20/142, 20/144 and 20/140 for panels A and C (20/140 and 20/144 for panels B, D and E) with almost identical values, 20/148, 20/150). Orange and blue numbers give the percentage of true positive and true negative samples, which were correctly detected by the tests. Square root R of coefficients of determination is given for association among continuous variables.
Article Snippet: Blood plasma was tested with quantitative assays
Techniques:
Journal: medRxiv
Article Title: In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients
doi: 10.1101/2021.02.19.21252080
Figure Lengend Snippet: Bivariate comparisons shown as violin and scatter plots for quantitative Ro-RBD-Ig-quant vs NT at indicated dilutions ( A ) and vs GS-cPass ( B ) and for quantitative EI-S1-IgG-quant vs NT at indicated dilutions ( C ) and vs GS-cPass ( D ). Black dashed lines represent manufacturers’ cut-off values and red dotted lines represent the WHO-standards (from the bottom to the top: 20/142, 20/144 and 20/140 for panel A (20/140 and 20/144 for panel C) with almost identical values, 20/148, 20/150). Orange and blue numbers give the percentage of true positive and true negative samples, which were correctly detected by the tests. Bold dashed lines are linear fit and grey areas surrounding them represent 95% CI; for the interested region, the polynomial fit was within the 95% CI of the linear fit. Square root R of coefficients of determination is given for association among continuous variables. Pairwise comparison between NT dilution categories (for A and C ) after adjustment for multiple comparison are shown in Table S2.
Article Snippet: Blood plasma was tested with quantitative assays
Techniques: Comparison
Journal: medRxiv
Article Title: In search for the SARS-CoV-2 protection correlate: A head-to-head comparison of two quantitative S1 assays in a group of pre-characterized oligo-/asymptomatic patients
doi: 10.1101/2021.02.19.21252080
Figure Lengend Snippet: Shown as proportion of alignment of Ro-RBD-Ig-quant ( A ) and EI-S1-IgG-quant ( B ) with NT dilution categories ≥1:5 and ≥1:10 and cPass categories ≥20% and ≥30%. Red dotted lines represent the WHO-standards (from the left to the right: 20/142, 20/144 and 20/140 for panel A [20/140 and 20/144 for panel B] with almost identical values). Table ( C ) details the lowest values (95% accordance of the positive predictive value [95% CI]) of the quantitative tests for which NT is ≥1:5 and ≥1:10 and cPass is ≥20% and ≥30%. CI, confidence interval; NT, neutralization
Article Snippet: Blood plasma was tested with quantitative assays
Techniques: Neutralization